Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04777240
Other study ID # Soh-Med-21-02-19
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 1, 2020
Est. completion date March 10, 2021

Study information

Verified date February 2021
Source Sohag University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Study on Characterization of Enterococci because nowadays it become an important cause of nosocomial infections .detection of the most common two species of Enterococci and most common virulence factors & its genes with determination of antibiotics sensitivity test for the isolated strains


Recruitment information / eligibility

Status Completed
Enrollment 52
Est. completion date March 10, 2021
Est. primary completion date February 28, 2021
Accepts healthy volunteers
Gender All
Age group 2 Months to 90 Years
Eligibility Inclusion Criteria: - any patients in ICU has manifestations of urinary tract infections, surgical wound infections, intra-abdominal infections, intrapelvic infections, bacteraemia and infective endocarditis Exclusion Criteria: - patients receiving antibiotics in previous 48 hours

Study Design


Related Conditions & MeSH terms

  • Samples From Patients With Enterococcal Infections

Locations

Country Name City State
Egypt Sohag Faculty of Medicine Sohag

Sponsors (1)

Lead Sponsor Collaborator
Sohag University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary I) Sample collection Samples are collected from intensive care unit (ICU) including urine, pus swabs, sputum, blood, tracheal aspirates and pharyngeal swabs 2 months
Primary II) Identification of Enterococci: by inoculation on Bile esculin azide & growing colonies further identified by :
microscopically after staining by gram stain
catalase test
grow on high concentration of NaCl (6.5%)
2 month
Primary III) Phenotypic detection of virulence marker of Enterococci(Gelatinase activity) by culture on nutrient agar containing gelatin.Positive results appeared as liquefaction of gelatin 2 weeks
Primary IV)Phenotypic detection of virulence marker of Enterococci (hemolytic activity) by Detection of hemolytic activity on the blood agar 1 week
Primary V) Phenotypic detection of virulence marker of Enterococci(Caseinase production) by Detection of Caseinase production on Muller hinton agar containing skimmed milk 3%. 2 weeks
Primary VI) Phenotypic detection of virulence marker of Enterococci(Formation of Slime layer) Formation of Slime layer by culture on Brain heart infusion agar containing 5% sucrose, plates are incubated for 24 hrs at 37oC. Positive strains gave mucoid and slimy colonies. 1 week
Primary VII) Phenotypic detection of virulence marker of EnterococcI (Biofilm formation) using microtiter plate reader. Biofilm formation is scored as nonbiofilm forming (-), weak - (+), moderate - (++), and strong - (+++) corresponding to the A630 values =1, 1-=2, 2-=3, and>3, respectively 2 weeks
Primary VIII) Antibiotic sensitivity test: by 1- disc diffusion test using Vancomycin 30 µg, Teichoplanin 30 µg, Tetracycline 30 µg, Ampicillin 10 µg and Erythromycin 15 µg. Results ,Results are interpreted according to CLSI 2018.
E-test:
MICs (minimal inhibitory concentrations) of Vancomycin are measured by E-test for confirmation of vancomycin resistance among the isolated Enterococci. Results are interpreted according to CLSI guidelines.
3 monthe
Primary IX) Molecular Identification of commonest Enterococcus species by conventional gene specific uniplex PCR for E. faecalis and E. Faecium 1 month
Primary X) Molecular detection of virulence genes Identification of virulence genes; gel E (gene for gelatinase), asa1 (gene for aggregation substance), cylA (gene for cytolysin activator), esp (gene for Enterococcal surface protein) Hyl (gene for Hyaluronidase) of E. faecalis and E. faecium was performed by uniplex PCR.The amplified products are visualized on 2% agarose gel stained with ethidium bromide. The stained gels are visualized and documented with a gel documentation system and analyzed visually to determine the size of PCR amplicons of the target genes directly by comparison with 100 bp DNA ladder marker. 2 months